miR Scientific, LLC

miR Scientific, LLC

5
(354)
Écrire un avis
Plus
€ 19.00
Ajouter au panier
En Stock
Description

miR Scientific, LLC | 1 395 abonnés sur LinkedIn. miR Scientific is a healthcare company that is committed to transforming cancer management globally. | miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers.
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers. Such new standards are urgently needed given the prevalence of these cancers and their debilitating burden globally. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in New York City with operating subsidiaries in Israel, Canada, and Puerto Rico.

Margie Abrams - Executive Assistant at miR Scientific, LLC at miR Scientific

miR Scientific, LLC

Tahirah W. - St. John's University, The Peter J. Tobin College of Business - New York, New York, United States

MiR-4458 inhibited cell proliferation by down-regulating STAT3. A

Fredy Miguez - Lead Clinical Technologist - miR Scientific, LLC

miR Sentinel™ The Future Of Prostate Cancer Tests

MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells

miR Scientific announces FDA Breakthrough Device Designation for its Prostate Cancer Liquid Biopsy Test

Sam Salman - 2022sv - PMWC Precision Medicine World Conference

Mir Imran - Wikipedia

IJMS, Free Full-Text

Margie Abrams - miR Scientific, LLC

Jamie V. Fortune - Director of Logistics & Operations - miR Scientific, LLC